On this ALCSI podcast, Ms. Denise Lee talks about her journey as a lung cancer survivor and advocate. Denise is a 4.5-year lung cancer survivor. She is also an avid reader and loves to travel. She was born and raised in the Midwest, went to college on the east coast and attended law school on the west coast. If she had to pick a phrase that encapsulates her journey, she'd say "a billboard saved my life...literally!" She is joining us with the American Lung Cancer Screening Initiative to share her story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Dr. Lary Robinson, a thoracic surgeon at the Moffitt Cancer Center, shares his expertise and research on lung cancer and lung cancer screening.  

Dr. Robinson, a native of Kansas, received his undergraduate B.A. degree in anthropology at the University of Kansas and his medical degree from the Washington University School of Medicine in St. Louis, Missouri. He completed his internship and residency in general and cardiothoracic surgery at the Duke University Medical Center. Additionally, he completed a fellowship in cardiac research and clinical cardiac surgery at the St. Thomas Hospital in London. He also served as a Flight Surgeon at the rank of Major, USAF in Thailand during the Vietnam War.  

A Diplomat of the American Board of Surgery, the American Board of Thoracic Surgery as well as certified in Surgical Critical Care, Dr. Robinson began his practice at the University of Nebraska Medical Center where he was an Associate Professor of Surgery and Pharmacology and the Clinical Director of the Clinical Perfusion Science Education Program. Dr. Robinson then came to the University of South Florida College of Medicine in Tampa in 1994 where he is currently a Professor of Surgery (Thoracic) and Interdisciplinary Oncology. He practices thoracic surgical oncology at the Moffitt Cancer Center as a Senior Member of the Moffitt Medical Group. He is also Director of the Pancoast Tumor Program in the Department of Thoracic Oncology. Recently he helped found the Center for Infection Research in Cancer (CIRC) in 2012. He is also the co-founder and President of Prelude to a Cure, Inc., a non-profit charity dedicated to raising funds to support lung cancer research.  

Dr. Robinson is the author or co-author of over 160 medical publications. He is directly involved as Principal Investigator in 2 ongoing clinical cancer research protocols involving lung cancer and the microbiome, as well as lung cancer in never-smoking women. He is also a Co-Principal Investigator for a prospective multi-center clinical study evaluating the influence of the gut microbiome on the effectiveness of immunotherapy for advanced lung cancer. Clinically, he is a member of the multidisciplinary thoracic oncology group involved in the evaluation and treatment of all stages of lung cancer, thymoma, and other thoracic cancers which includes aggressive, combined modality therapy including numerous clinical trials.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Mrs. Lisa Goldman talks about her journey as a lung cancer survivor and advocate. She was diagnosed with ROS1+ Stage IV NSCLC in 2014. She co-founded The ROS1ders, Inc. and currently serves as the Vice President and sits on their Board of Directors (see www.ros1ders.org). Lisa is also a member of the Pfizer Lung Cancer Steering Committee and a Patient Advocate for the Lung Cancer Foundation of America. She speaks at medical conferences both internationally and in the USA and blogs at Every Breath I Take. Lisa previously worked as a fitness instructor and lawyer. She is joining us with the American Lung Cancer Screening Initiative to share her story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Mrs. Valerie Vanderford talks about her journey as a lung cancer survivor. Valerie is a mom, grandma, wife, gardener, photographer, and 10.5-year lung cancer survivor. A nagging cough led to a myriad of tests and ultimately the diagnosis of Stage IIIB lung cancer in 2011. She had her right lung removed shortly afterward, and has been "NED" (no evidence of disease) ever since. She credits a positive attitude, along with some natural supplements, for her survival and preventing the recurrence of cancer. She is joining us with the American Lung Cancer Screening Initiative to share her story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Mrs. Yovana Portillo talks about her journey as a lung cancer survivor and advocate. Yovana was a passenger in a car accident in the spring of 2016 that led to a visit to the ER, where a mass on her left lung was discovered during the examination. At 35, living a pretty active lifestyle and without any other major health ailments, Yovana was shocked when she heard her diagnosis of Stage IB Mucinous Adenocarcinoma Non-Small Cell Lung Cancer. Yovana is now a strong advocate for lung cancer, hoping to end the stigma associated with the disease, increase research funding, and raise awareness that lung cancer can happen to anyone, all you need is lungs. She is joining us with the American Lung Cancer Screening Initiative to share her story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Mrs. Heidi Nafman-Onda talks about her journey as a lung cancer survivor and advocate, and Dr. Pierre Onda talks about his experience as a caregiver for Heidi. Heidi and Pierre are high school sweethearts since 1979 and married 36 years. They are the co-founders of The White Ribbon Project, which aims to change the public perception of lung cancer with the message, “Anyone with lungs can get lung cancer and no one deserves it.” Heidi, a lifelong health enthusiast with no smoking history, was diagnosed with Stage IIIA cancer of the lung in October of 2018. Pierre is Heidi’s caregiver and a recently retired primary care physician. Lung cancer rocked their world and they are fighting back strong and encouraging the lung cancer community to unify, stand tall, and increase lung cancer awareness by becoming visible and vocal, humanizing this misunderstood disease. They are joining us with the American Lung Cancer Screening Initiative to share their story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Ms. Diane Colton talks about her journey as a lung cancer survivor and advocate. Diane was diagnosed with lung cancer in 2011, 2012, and 2019. After her second diagnosis in 2012, she learned the reality of having lung cancer and began paying attention to the stigmas that cancer carries with it. Like most people diagnosed with one of the over 50 types of cancers of the lung, she knew nothing. The more she read, the stronger her desire to do something to hopefully be a pebble that would create an avalanche of change. Because she is in good health, she has the ability to do much more than the over 90% who continue to fight to live. Diane began her advocating in 2014, and, throughout her personal battle with cancer and surgery and treatments, she has continued with both her day job and her advocacy work. When her cancer returned in 2019 as a brain tumor, she underwent three stereotactic radiation treatments and, after recovery, went right back to work at both jobs. She is joining us with the American Lung Cancer Screening Initiative to share her story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Mr. Edward Cutler talks about his journey as a lung cancer survivor and advocate. Mr. Cutler was diagnosed in 2013 with stage IV non-small cell lung cancer (NSCLC). He is a native of Tampa, Florida, and went to Pennsylvania for college and met his wife, Donna, there. After getting married and serving in the U.S. Navy in the Vietnam War, they moved back to Tampa. He worked as a certified public accountant and tax consultant for over 50 years until his retirement earlier this year. Mr. Cutler and his wife have two adult children and three grandchildren, all of whom live on opposite coasts of the USA.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Mrs. Donna Hunting talks about her journey as a lung cancer survivor and advocate. Donna is a non-smoker who was diagnosed with lung cancer at the age of 54. She has non-small cell lung cancer, adenocarcinoma with the EGFR Exon 19 mutation. Since diagnosis, she has been NED (no evidence of disease) two times in her journey and is currently on her third treatment line. She is joining us with the American Lung Cancer Screening Initiative to share her story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.

On this ALCSI podcast, Mrs. Katja Broddesson talks about her journey as a lung cancer survivor and advocate. Katja was diagnosed with stage IV non-small cell lung cancer adenocarcinoma and stage II non-Hodgkin's lymphoma as a 47-year-old non-smoker. Since then she had clean scans! She is joining us with the American Lung Cancer Screening Initiative to share her story.  

Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, more than 30,000 lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.